Истраживачи
Jukić, Marin
Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
---|---|---|---|---|
2024 | Current level of evidence for improvement of antidepressant efficacy andtolerability by pharmacogenomic-guided treatment: A Systematic reviewand meta-analysis of randomized controlled clinical trials (✓) | Milosavljević, Filip ![]() ![]() ![]() ![]() | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2024 | A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study (✓) | Pelgrim, Teuntje A. D.; Philipsen, Alexandra; Young, Allan H.; Juruena, Mario ![]() ![]() ![]() ![]()
Kas, Martien J. H.; Jagesar, Raj R.; Nöthen, Markus M.; Hoffmann, Per; Shomron, Noam; Kilarski, Laura L; van Amelsvoort, Thérèse; Campforts, Bea; van Westrhenen, Roos;
| Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2023 | The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia | Milosavljević, Filip ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2022 | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability (✓) | Joković, Danilo; Milosavljević, Filip ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2022 | Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population | Bråten, Line Skute; Ingelman-Sundberg, Magnus; Jukić, Marin ![]() ![]() | Научни чланак | 22M22 - Рад у истакнутом међ. часопису |
2022 | Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits | Lenk, Hasan Çağın; Løvsletten Smith, Robert; O'Connell, Kevin; Jukić, Marin ![]() ![]() | Научни чланак | 22M22 - Рад у истакнутом међ. часопису |
2022 | Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching A Retrospective, Naturalistic Cohort Study Using Therapeutic Drug Monitoring Data From 640 Patients | Frederiksen, Trine; Smith, Robert Lovsletten; Jukic, Marin M ![]() ![]() | Научни чланак | 22M22 - Рад у истакнутом међ. часопису |
2022 | Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids | Pridgeon, Chris; Bolhuis, Dian; Milosavljević, Filip ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2022 | The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients | Lenk, Hasan Çağın; Klöditz, Katharina; Johansson, Inger; Løvsletten Smith, Robert; Jukić, Marin ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2022 | Patients’ and psychiatrists’ stance on the current state of pharmacological depression treatment in Serbia and prospects of introduction of personalized pharmacotherapy and its potential effects | Jeremić, Aleksandra ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 52M52 - Рад у истакнутом нац. часопису |
2022 | Pharmacogenomics in treatment of depression and psychosis: an update | Jukić, Marin ![]() ![]() ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2021 | CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry | Molden, Espen; Jukić, Marin ![]() ![]() | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2021 | Validation of a quick and simple chromatographic method for simultaneous quantification of sertraline, escitalopram, risperidone and paliperidone levels in the human plasma | Jeremić, Aleksandra ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 52M52 - Рад у истакнутом нац. часопису |
2021 | Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates | Jukic, Marin M ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2021 | Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy (✓) | Stanić, Dušanka ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2021 | Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders | Smith, Robert; Tveito, Marit; Kyllesø, Lennart; Jukić, Marin ![]() ![]() | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2021 | Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis (✓) | Milosavljevic, Filip ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2021 | A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram | Braten, Line Skute; Haslemo, Tore; Jukic, Marin M ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
2020 | Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going? | van Westrhenen, Roos; Aitchison, Katherine J.; Ingelman-Sundberg, Magnus; Jukić, Marin ![]() ![]() | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
2020 | Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients | Braten, Line Skute; Haslemo, Tore; Jukic, Marin M ![]() ![]() | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |